Scarica l'app Stockscreener
11.66
1.35%
-0.16
Dopo l'orario di chiusura:
11.66
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OCUL Giù?
Forum
Previsione
Precedente Chiudi:
$11.82
Aprire:
$11.81
Volume 24 ore:
2.64M
Relative Volume:
0.99
Capitalizzazione di mercato:
$2.03B
Reddito:
$61.10M
Utile/perdita netta:
$-138.36M
Rapporto P/E:
-8.637
EPS:
-1.35
Flusso di cassa netto:
$-90.59M
1 W Prestazione:
+1.48%
1M Prestazione:
-0.26%
6M Prestazione:
+40.48%
1 anno Prestazione:
+10.73%
Intervallo 1D:
$11.65
$12.07
Intervallo di 1 settimana:
$11.25
$12.10
Portata 52W:
$5.80
$13.85
Ocular Therapeutix Inc Stock (OCUL) Company Profile
Nome
Ocular Therapeutix Inc
Settore
Industria
Telefono
781-357-4000
Indirizzo
15 CROSBY DRIVE, BEDFORD, MA
Confronta OCUL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OCUL
Ocular Therapeutix Inc
|
11.66 | 2.50B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-15 | Iniziato | Chardan Capital Markets | Buy |
| 2025-04-08 | Iniziato | William Blair | Outperform |
| 2025-03-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-03-11 | Iniziato | Needham | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-20 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-31 | Ripresa | Piper Sandler | Overweight |
| 2024-02-09 | Iniziato | BofA Securities | Buy |
| 2023-04-21 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-10 | Ripresa | Berenberg | Buy |
| 2021-08-10 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-12-28 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-11-13 | Reiterato | Raymond James | Strong Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-05-21 | Downgrade | Cowen | Outperform → Market Perform |
| 2019-05-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-05-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2018-12-03 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-11-15 | Iniziato | Raymond James | Strong Buy |
| 2018-09-07 | Iniziato | Piper Jaffray | Overweight |
| 2017-10-24 | Iniziato | Guggenheim | Buy |
| 2017-07-26 | Iniziato | H.C. Wainwright | Buy |
| 2017-07-12 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2017-02-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-08-11 | Iniziato | JMP Securities | Mkt Outperform |
| 2016-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-10-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2015-08-13 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie
Multi asset correlation models including Ocular Therapeutix Inc.Market Performance Recap & Weekly Return Optimization Alerts - newser.com
Is Ocular Therapeutix Inc. stock oversold or undervalued2025 Trading Volume Trends & Daily Growth Stock Tips - newser.com
Short interest data insights for Ocular Therapeutix Inc.Trade Performance Summary & Community Verified Watchlist Alerts - newser.com
Will Ocular Therapeutix Inc. stock go up soon2025 Trading Recap & Daily Entry Point Trade Alerts - newser.com
How to recover losses in Ocular Therapeutix Inc. stockJuly 2025 Sector Moves & Community Consensus Trade Alerts - newser.com
Why Ocular Therapeutix Inc. stock appeals to analystsEarnings Performance Report & Weekly Stock Performance Updates - newser.com
Is Ocular Therapeutix Inc. (0OT) stock positioned for digital growth eraWeekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com
Real time scanner hits for Ocular Therapeutix Inc. explained2025 Dividend Review & Community Consensus Trade Alerts - newser.com
Can Ocular Therapeutix Inc. (0OT) stock beat analyst consensusJuly 2025 Update & AI Driven Stock Reports - newser.com
What institutional flow reveals about Ocular Therapeutix Inc.July 2025 Institutional & Verified Short-Term Plans - newser.com
Why analysts upgrade Ocular Therapeutix Inc. stockJuly 2025 PreEarnings & Capital Efficient Trade Techniques - newser.com
Ocular Therapeutix (NASDAQ:OCUL) Price Target Raised to $20.00 - MarketBeat
Ocular Therapeutix (OCUL) Projected to Post Earnings on Tuesday - MarketBeat
How Ocular Therapeutix Inc. (0OT) stock behaves in tightening cyclesQuarterly Profit Report & Fast Entry Momentum Trade Alerts - newser.com
Why Ocular Therapeutix Inc. (0OT) stock is trending on social mediaWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
Is Ocular Therapeutix Inc. stock a buy in volatile marketsWeekly Profit Recap & Verified Technical Trade Signals - newser.com
Is this a good reentry point in Ocular Therapeutix Inc.Market Volume Summary & Long Hold Capital Preservation Tips - newser.com
Using Ichimoku Cloud for Ocular Therapeutix Inc. technicalsMarket Activity Recap & Free Weekly Chart Analysis and Trade Guides - newser.com
Detecting support and resistance levels for Ocular Therapeutix Inc.Layoff News & Verified Momentum Stock Alerts - newser.com
Can Ocular Therapeutix Inc. hit a new high this monthMarket Growth Summary & Reliable Breakout Stock Forecasts - newser.com
Is Ocular Therapeutix Inc. stock undervalued vs historical averages2025 Trade Ideas & AI Based Buy/Sell Signal Reports - newser.com
How Ocular Therapeutix Inc. (0OT) stock responds to job market shifts - newser.com
Ocular Therapeutix (OCUL): TD Cowen Raises Price Target, Reaffir - GuruFocus
Wall Street Analysts Believe Ocular Therapeutix (OCUL) Could Rally 82.93%: Here's is How to Trade - sharewise.com
Ocular Therapeutix Inc Azioni (OCUL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):